Beta-blockers and amiodarone for the primary prevention of sudden cardiac death

Current Cardiology Reports

Volumn 1, Issue 4, 1999, Pages 274-281

  Frankenberger, Olivier ^a   Steinber, Jonathan S ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUDDEN DEATH; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; VENTRICULAR FIBRILLATION;

EID: 0033222262     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-999-0050-8     Document Type: Article

References (49)

1. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In In Heart Disease: A Textbook of Cardiovascular Medicine. Edited by Braunwald E. Philadelphia: WB Saunders; 1997:742-779.
2. Friedman M, Manwaring JH, Rosenman RH, et al.: Instantaneous and sudden deaths: Clinical and pathological differentiation in coronary artery disease. JAMA 1973, 225:1319-1328.
3. Kuller KH, Perper JA, Dai WS, et al.: Sudden death and the decline in coronary artery disease mortality. J Chronic Dis 1986, 39:1001-1019. (Pubitemid 17203151)
4. Engelstein ED, Zipes DP: Sudden cardiac death. In The Heart, Arteries and Veins. Edited by Alexander RW, Schlant RC, Fuster V New York: McGraw-Hill; 1998 1081-1112.
5. Myerbur RJ, Kessler KM, Castellanos A, et al.: Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993, 119:1187-1197. (Pubitemid 23361449)
6. Myerbur R, Kessler KM, Bassett AL, et al.: A biological approach to sudden cardiac death: Structure, function and cause. Am J Cardiol 1989, 63:1512 1516.
7. Willich SN, Maclure M, Mittelman M, et al.: Sudden cardiac death: Support for a role of triggering in causation. Circulation 1993, 87:1442-1450. (Pubitemid 23133086)
8. Muller JE, Kaufmann PG, Luepker RV, et al., for the Mechanisms Precipitating Acute Cardiac Events Participants: Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. Circulation 1997, 96:3233-3239. (Pubitemid 27500130)
9. Green HL: Sudden arrhythmic cardiac death: Mechanisms, resuscitation and classification: The Seattle perspective. Am J Cardiol 1990, 65:4B-12B.
10. Bayes de Luna AB, Coumel P, Leclercq J, et al.: Ambulatory sudden cardiac death: Mechanism of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989, 117:151-159. (Pubitemid 19043766)
11. Luu M, Stevenson WG, Stevenson LW, et al.: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989, 80:1675-1680. (Pubitemid 20031698)
12. Janse MJ, Wit AL: Electrophysiologic mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989, 69:1049-1154.
13. Pogwizd SM, Corr PB: Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia. Circ Res 1990, 66:672-695. (Pubitemid 20086908)
14. Parker GW, Michael LH, Hartley CJ: Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res 1990, 66:259-270. (Pubitemid 20041158)
15. Åblad B, Bjurö T, Björkman JA, et al.: Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone [abstract]. J Am Coll Cardiol 1991, 17(suppl A):165.
16. Bigger JT, La Rovere MT, Steinman RC, et al.: Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol 1989, 14:1511-1518. (Pubitemid 19279052)
17. Cerati D, Schwartz PJ: Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death Circ Res 1991, 69 1389 1401.
18. The MIAMI Trial Research Group: Metoprolol in Acut Myocardial Infarction (MIAMI): a randomized placebocontrolled international trial. Eur Heart J 1985, 6:199-226.
19. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propanolol in patients with acute myocardial infarction, I: mortality results. JAMA 1982, 247:1407-1414.
20. Hjalmarson Å, Elmfeldt D, Herlitz J, et al.: Effect on mortality of metoprolol in acute myocardial infarction: a double blind randomized trial. Lancet 1981, 2:823-827. (Pubitemid 11017550)
21. Rydén L, Arineigo R, Arnman K, et al.: A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachyarrhythmias N Engl J Med 1983, 308:614-618.
22. Ryan T, Anderson J, Antman E, et al.: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1996, 94:2341-2350.
23. Cohn JN, Johnson G, Ziesche S, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991, 325:303-310.
24. Fonorow GC, Chelimsky-Fallick C, Stevenson LW, et al.: Effect of direct vasodilatation vs angiotensin-converting enzyme inhibition on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol 1992, 19:842-850.
25. Keogh AM, Baron DW, Hickie JB, et al.: Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990, 65:903-908. (Pubitemid 20114528)
26. Waagstein F, Hjalmarson A, Varnauskas E, et al.: Effect of chronic beta-adrenergic blockade in congestive cardiomyopathy. Br. Heart J 1975, 37:1022-36.
27. Waagstein F, Bristow MR, Swedberg, et al.: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993, 342:1441 1446. (Pubitemid 24000287)
28. Fisher ML, Gottlieb SS, Plotnick GD, et al.: Beneficial effects of metoprolol in heart failure associated with coronary artery disease. J Am Coll Cardiol 1994, 23:943-950. (Pubitemid 24090881)
29. Eichhorn EJ, Heesch CM, Barnett JH, et al.: Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardio 1994, 24 1310-1320. (Pubitemid 24331872)
30. CIBIS Investigators and Committees: A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994, 90:1765-1773. 31. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999, 353 9-13.
31. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001-2007.
32. Packer M, Bristow MR, Cohn J, et al., for the US Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349-1355. (Pubitemid 26152713)
33. Australia-New Zealand Heart Failure Research Collaborative Group: Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995, 92:212 218.
34. Colucci WS, Packer M, Bristow MR, et al.: Carvedilol inhibits clinical progression in patients with mild heart failure. Circulation 1996, 94:2800 2806. (Pubitemid 26411744)
35. Bristow MR, Gilbert EM, Abraham WT, et al.: Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996, 94:2807-2816. (Pubitemid 26411745)
36. Gilbert E, Abraham W, Olsen S, et al.: Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996, 94:2817-2825. (Pubitemid 26411746)
37. Weinberg BA, Miles WM, Klein LS, et al.: Five-year follow-up of 589 patients treated with amiodarone. Am Heart J 1993 109-120. (Pubitemid 23021632)
38. Herre JM, Sauve MJ, Malone P, et al.: Long term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989, 13:442-449. (Pubitemid 19055672)
39. Doval HC, Nul DR, Grancelli HO, et al.: Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994, 344:493-498.
40. Massie BM, Fisher SG, Radford M, et al.: Effect of amiodaron on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation 1996, 93:2128-2134. (Pubitemid 26187102)
41. Singh SN, Fletcher RD, Fisher SG, et al.: Amiodarone in patients with congestive heart failure and symptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therap in Congestive Heart Failure. N Engl J Med 1995, 333 77-82.
42. The Cardiac Arrhythmia Suppresion Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992, 327:227-233.
43. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989, 321:406-412.
44. Burkart F, Pfisterer M, Kiowski W, et al.: Effect of antiarrhythmic therapy on mortality of survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS), J Am Coll Cardiol 1990, 16:1711-1718.
45. Cairns JA, Connolly SJ, Roberts R, et al.: Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations CAMIAT. Lancet 1997, 349:675-682. (Pubitemid 27107745)
46. Julian DG, Camm AJ, Frangin G, et al.: European Myocardial Infarct Amiodarone Trial Investigators. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997, 349:667-674. (Pubitemid 27107744)
47. Janse MJ, Malik M, Camm AJ, et al.: Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substud of EMIAT. Eur Heart J 1998, 9:85-95.
48. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al.: Effect of amiodarone on mortality after myocardial infarction: a double blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992, 20:1056 1062.
49. Klein H, Auricchio A, Reek S, et al.: New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999, 83:91D-97D. (Pubitemid 29125071)